Results 41 to 50 of about 4,350 (187)
Systemic lupus erythematosus with subacute cutaneous manifestation – acute on chronic.
Galicia Clínica, 2018 Systemic Lupus Erythematosus (SLE) presents as a continuum, with some patients demonstrating only cutaneous manifestations, such as Chronic Cutaneous Lupus Erythematosus (CCLE) or other more severe organ manifestations as in SLE.
Juliana Lopes, Isabel Almeida
doaj +1 more source
A case of subacute cutaneous lupus erythematosus as a result of ranibizumab (Lucentis) treatment
Indian Journal of Ophthalmology, 2013 Cutaneous lupus erythematosus is a previously undiagnosed side-effect of ranibizumab. Here, we present a case of an 82-year-old female Caucasian patient with wet age-related macular degeneration.
Marko Andric +4 more
doaj +1 more source
Subacute Cutaneous Lupus Erythematosus
Journal of Investigative Dermatology, 1993 Gilliam recognized subacute cutaneous lupus erythematosus (SCLE) as a lupus-specific eruption that identifies a unique subset of lupus erythematosus. These patients were noted to have prominent photoaggravated skin disease and often had musculoskeletal complaints, but generally did not develop significant systemic disease.
openaire +4 more sources
Autoimmune hepatitis overlapping with subacute cutaneous lupus erythematosus: A case report
Asian Journal of Internal Medicine, 2023 Autoimmune hepatitis (AIH) is an autoimmune liver disorder which rarely coexists with systemic lupus erythematosus (SLE) and presents as an overlap syndrome affecting multiple organs.
M. H. Jazeer, U. Maheshwaran
doaj +1 more source
Ticlopidine-induced subacute cutaneous lupus erythematosus: A case report and literature review
Dermatologica Sinica, 2014 Many drugs have been reported to induce lupus in a minority of patients. Ticlopidine hydrochloride inhibits platelet aggregation and is widely used for the prevention of thrombosis. There have been only a few reports of ticlopidine-induced lupus.
Yi-Ching Chen, Yu-Hung Wu
doaj +1 more source
Congenital lupus erythematosus
Indian Journal of Dermatology, 2011 Neonatal lupus erythematosus (NLE) is an autoimmune disease affecting the fetus as a result of transplacental transfer of anti-Ro autoantibodies. Typically, it presents in the first few months of life with an annular form of subacute cutaneous lupus ...
Taseer Ahmed Bhatt +2 more
doaj +1 more source
Anais Brasileiros de Dermatologia, 2004 Os autores relatam caso de lúpus eritematoso cutâneo subagudo (LECSA) manifestado clinicamente como eritema anular centrífugo. Ressaltam a diferenciação clínica e laboratorial entre LECSA e lúpus eritematoso sistêmico.
Ney Romiti +4 more
doaj +1 more source
Neonatal lupus erythematosus presenting as Stevens-Johnson syndrome
Dermatologica Sinica, 2018 Neonatal lupus erythematosus (NLE) is a rare acquired condition caused by the transplacental passage of maternal autoantibodies. It is characterized by cutaneous, cardiac, hepatobiliary, hematological and neurological involvement.
Ren-Feng Liu +4 more
doaj +1 more source
Effect of Belimumab on the Cutaneous Manifestations of Patients With Lupus Erythematosus
International Journal of Dermatology, EarlyView.ABSTRACT Background The aim was to assess the long‐term effect of belimumab on the cutaneous manifestations of patients with systemic lupus erythematosus (SLE). Methods The retrospective analysis included 29 patients with SLE. Cutaneous disease activity was assessed using the Cutaneous Lupus Erythematosus Disease Area and Severity Index (CLASI) and the
Diana Schellin +5 more
wiley +1 more source
Litifilimab efficacy on skin outcomes in cutaneous lupus erythematosus in the Phase 2 LILAC study
Journal of the European Academy of Dermatology and Venereology, EarlyView.Our findings show that greater proportions of litifilimab‐treated participants than placebo experienced 20%, 50%, 70% or 90% improvements in CLASI‐A score from baseline and CLASI‐A scores of 0–1 or 0–3. Similar results were observed using physician global assessments, supporting the Phase 2 LILAC study primary analysis in CLE.
Victoria P. Werth +8 more
wiley +1 more source